Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-21-000058
Filing Date
2021-10-28
Accepted
2021-10-28 16:22:30
Documents
87
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20210930.htm   iXBRL 10-Q 2486634
2 EX-31.1 opk-9302021xex311.htm EX-31.1 9415
3 EX-31.2 opk-9302021xex312.htm EX-31.2 9392
4 EX-32.1 opk-9302021xex321.htm EX-32.1 3697
5 EX-32.2 opk-9302021xex322.htm EX-32.2 3730
  Complete submission text file 0000944809-21-000058.txt   12035158

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20210930.xsd EX-101.SCH 74950
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20210930_cal.xml EX-101.CAL 99689
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20210930_def.xml EX-101.DEF 449117
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20210930_lab.xml EX-101.LAB 952317
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20210930_pre.xml EX-101.PRE 636856
11 EXTRACTED XBRL INSTANCE DOCUMENT opk-20210930_htm.xml XML 2269095
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 211358612
SIC: 2834 Pharmaceutical Preparations